The World Anti-Doping Agency (WADA) has withdrawn from the 2011 list of prohibited substances and methods the intramuscular treatment known as PRP, which includes PRGF, the treatment with autologous growth factors (from the patient himself), developed by the Spanish doctors Eduardo Anitua and Mikel Sánchez. This procedure, which greatly accelerates tissue regeneration times to allow an earlier return to sports, had been included by WADA in the 2010 list of prohibited substances and methods for use in muscular injuries, although it was allowed both for tendon and ligament injuries.
Thanks to the mediation of the Spanish Olympic Committee (COE), the innovative treatment of the Spanish doctors Eduardo Anitua and Mikel Sánchez has been allowed again by the World Anti-Doping Agency. Over the period of one year, the Spanish doctors have been providing scientific evidence to demonstrate that their innovative injury treatment does not result in any doping. The evidence, in form of extensive documentation that was first submitted to the Spanish Anti-Doping Agency, then to the Medical Commission of the International Olympic Committee and finally to the World Anti-Doping Agency, convinced the members of the WADA that the pioneering treatment of the two Spanish doctors is not performance enhancing.
November 2010
Innovation Seal 2010
BTI has been awarded with the second prize of “Innovation Seal 2010” awards at “best R+D infrastructure” category. This is the recognition to the several developments done at business network. The “Innovation Seal 2010” Awards are organised by the Association of Science and Technology Parks of Spain (APTE), with the support of the Spanish Ministry of Science and Innovation.